【结 构 式】 |
【分子编号】38043 【品名】2-acetyl-6-[(3R,4R)-3-(acetoxy)-1-methylpiperidinyl]-3,5-dimethoxyphenyl 2-chlorobenzoate 【CA登记号】 |
【 分 子 式 】C25H28ClNO7 【 分 子 量 】489.95256 【元素组成】C 61.29% H 5.76% Cl 7.24% N 2.86% O 22.86% |
合成路线1
该中间体在本合成路线中的序号:(III)The condensation of acetophenone (I) with 2-chlorobenzoyl chloride (II) in pyridine gives the corresponding ester (III), which is treated with KOH in hot pyridine yielding the diketone (IV). The cyclization of (IV) with H2SO4 in acetic acid at 100 C affords the benzopyranone (V). The hydrolysis of the acetate group of (V) with NaOH in methanol/water affords the piperidinol (VI), which is finally demethylated with pyridinium hydrochloride at 210-20 C. Alternatively, the ester (III) can be cyclized directly to benzopyranone (V) by means of NaH in hot dioxane.
【1】 Naik, R.G.; Lal, B.; Rupp, R.H.; Sedlacek, H.H.; Dickneite, G.; Czech, J. (Aventis SA); Use of 4H-1-benzopyran-4-one derivs., 4H-1-benzopyran-4-one derivs. and medicines containing same. AU 8943841; DE 3836676; EP 0366061; JP 1990178225; US 5284856 . |
【2】 Tabaka, A.C.; et al.; Application of modified flavone closure for the preparation of racemic L86-8275. Org Process Res Dev 1999, 3, 4, 256. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 38042 | (3R,4R)-4-(3-acetyl-2-hydroxy-4,6-dimethoxyphenyl)-1-methylpiperidinyl acetate | C18H25NO6 | 详情 | 详情 | |
(II) | 14000 | o-Chlorobenzoyl chloride; 2-Chlorobenzoyl chloride | 609-65-4 | C7H4Cl2O | 详情 | 详情 |
(III) | 38043 | 2-acetyl-6-[(3R,4R)-3-(acetoxy)-1-methylpiperidinyl]-3,5-dimethoxyphenyl 2-chlorobenzoate | C25H28ClNO7 | 详情 | 详情 | |
(IV) | 38044 | (3R,4R)-4-[3-[3-(2-chlorophenyl)-3-oxopropanoyl]-2-hydroxy-4,6-dimethoxyphenyl]-1-methylpiperidinyl acetate | C25H28ClNO7 | 详情 | 详情 | |
(V) | 38045 | (3R,4R)-4-[2-(2-chlorophenyl)-5,7-dimethoxy-4-oxo-4H-chromen-8-yl]-1-methylpiperidinyl acetate | C25H26ClNO6 | 详情 | 详情 | |
(VI) | 38046 | 2-(2-chlorophenyl)-8-[(3R,4R)-3-hydroxy-1-methylpiperidinyl]-5,7-dimethoxy-4H-chromen-4-one | C23H24ClNO5 | 详情 | 详情 |